Pfizer vaccine
Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows
May 14, 2021Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news
The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
Pfizer commences process for full FDA approval of COVID-19 vaccine
May 10, 2021Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news
Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …
Pfizer vaccine 91.3% effective after six months, Phase III study shows
April 6, 2021Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine
Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …
North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data
February 16, 2021Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine
North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …
Pfizer COVID-19 vaccine proven 94% effective in biggest study yet
February 15, 2021Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus
The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …
Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study
September 16, 2020Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine
Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …
Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October
September 14, 2020Sales and Marketing Pfizer, Pfizer vaccine, Vaccine
Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
